当前位置:首页 >财报库 > 报告详情

西维斯健康CVS Health(CVS)2025年第四季度及全年财务业绩演示PPT「NYSE」(英文版)(12页).pdf

上传人: 1****1 编号:1123449 2026-02-11 12页 235.86KB

下载:

1、12026 CVS Health and/or one of its affiliates.Confidential and proprietary.Fourth Quarter 2025 February 10,2026J.David JoynerChair andChief Executive OfficerBrian O.NewmanExecutive Vice President andChief Financial OfficerEarnings Conference Call 22026 CVS Health and/or one of its affiliates.Confide

2、ntial and proprietary.Cautionary Statementconcerning forward-looking statementsThis presentation includes forward-looking statements.The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation(“CVS Health”)

3、.By their nature,all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify.Actual results may also differ materially from those contemplated by the forward-looking statements due to the

4、risks and uncertainties described in our Securities and Exchange Commission filings,including those set forth in the Risk Factors section and under the heading“Cautionary Statement Concerning Forward-Looking Statements”in our most recent Annual Report on Form 10-K,our recent Current Reports on Form

5、8-K and this mornings earnings press release.This presentation includes non-GAAP financial measures that we use to describe our companys performance.In accordance with SEC regulations,you can find the definitions of these non-GAAP measures,as well as reconciliations to the most directly comparable G

6、AAP measures,in our press release we issued in connection with the release of our results for the fourth quarter of 2025 and our non-GAAP reconciliation document,which are both available on the Investor Relations portion of our website.32026 CVS Health and/or one of its affiliates.Confidential and p

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **2025年Q4业绩**:营收1057亿美元(同比+8.2%),调整后EPS 1.09美元,GAAP EPS 2.30美元,运营现金流34亿美元。 2. **2026年指引**:调整后EPS 7.00-7.20美元,营收至少4000亿美元,调整后运营收入150.7-154.1亿美元,运营现金流至少90亿美元。 3. **业务亮点**: - **医疗保健福利**:Q4医疗福利比率94.8%,2026年调整后运营收入指引35.8-39.2亿美元。 - **健康服务**:Q4处理处方4.919亿张,2026年调整后运营收入至少72.5亿美元。 - **药店与消费者健康**:Q4同店药店销售额增19.3%,2026年调整后运营收入至少60.9亿美元。 4. **战略目标**:成为美国最受信赖的医疗保健公司,通过多元化业务和投资推动增长。
**2026业绩展望?** **医疗业务增长点?** **股东回报计划?**
客服
商务合作
小程序
服务号
折叠